InMed Pharmaceuticals Inc. filed an 8-K on February 11, 2026, reporting its financial results for Q2 of fiscal 2026, which ended on December 31, 2025. The filing indicates that the company is classified as an emerging growth company and includes additional exhibits for detailed financial information.